VHL Logo

    • Español
    • English
    • Português
    • Français
    Home > BIGG > Search result

    Results: 1

    Presentation, diagnosis, and medical management of heart failure in children: Canadian Cardiovascular Society guidelines

    Kantor, PF; Lougheed, J; Dancea, A; McGillion, M; Barbosa, N; Chan, C; Dillenburg, R; Atallah, J; Buchholz, H; Chant-Gambacort, C; Conway, J; Gardin, L; George, K; Greenway, S; Human, DG; Jeewa, A; Price, JF; Ross, RD; Roche, SL; Ryerson, L; Soni, R; Wilson, J; Wong, K.
    Can J Cardiol; 29 (12), 2013
    Pediatric heart failure (HF) is an important cause of morbidity and mortality in childhood. This article presents guidelines for the recognition, diagnosis, and early medical management of HF in infancy, childhood, and adolescence. The guidelines are intended to assist practitioners in office-based or em...
    Angiotensin II Type 1 Receptor Blockers/therapeutic use, Angiotensin-Converting Enzyme Inhibitors, Biomarkers/blood, Cardiotonic Agents, Catecholamines/therapeutic use, Diuretics, Vasodilator Agents, Vasopressins, Heart Defects, Congenital, Death, Sudden, Cardiac/etiology, Heart Failure, Myocarditis, Echocardiography, Electrocardiography, Ambulatory, Algorithms, Heart Defects, Congenital/diagnosis, Heart Defects, Congenital/therapy, Myocardium/pathology, Death, Sudden, Cardiac/prevention & control
    Fulltext
      Filters

      Main subject

      • Heart Defects, Congenital 1
      • Heart Failure 1

      SDG3

      • Infant mortality 1
      • Noncommunicable Diseases 1

      Document type

      • Article 1

      Language

      • English 1

      Year

      • 2013 1
      • Terms and conditions of use
      • Privacy Policy
      • WordPress version 4.9.8
      • BVS-Site Plugin version 0.6.0